HLB Therapeutics Market Cap

HLB Therapeutics has a market cap or net worth of 265.79 billion as of March 20, 2026. Its market cap has decreased by -67.36% in one year.

Market Cap

265.79B

Enterprise Value

284.53B

Revenue

63.25B

Ranking

n/a

PE Ratio

n/a

Stock Price

3,015.00

Market Cap Chart

Since March 26, 2010, HLB Therapeutics's market cap has increased from 105.80B to 265.79B, an increase of 151.21%. That is a compound annual growth rate of 5.93%.

Market Cap History

Date	Market Cap	% Change
Mar 20, 2026	265.79B	5.53%
Dec 30, 2025	251.87B	-73.05%
Dec 30, 2024	934.49B	182.02%
Dec 28, 2023	331.36B	-9.25%
Dec 29, 2022	365.14B	-3.64%
Dec 30, 2021	378.91B	-51.22%
Dec 30, 2020	Upgrade Pro	Upgrade Pro
Dec 30, 2019	Upgrade Pro	Upgrade Pro
Dec 28, 2018	Upgrade Pro	Upgrade Pro
Dec 28, 2017	Upgrade Pro	Upgrade Pro
Dec 29, 2016	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Anterogen.Co.,Ltd.	439.27B
GC Cell	398.97B
BINEX	394.91B
Bioneer	313.34B
JETEMA,	311.00B
Helixmith	260.63B
EASY BIO,Inc.	226.94B
Genexine	208.07B

Market Cap Rankings